ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared USA

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

FDA Grants Full Approval To Eli Lilly's Jaypirca For CLL/SLL
(RTTNews) - Eli Lilly and Co. (LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Jaypirca (pirtobrutinib, 100 mg and 50 mg tablets) for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL
Announcement as on 04 December 2025

Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales
LLY???s newest approvals and pipeline deals add fresh momentum to revenue growth as the company expands beyond its GLP-1 blockbusters.
Announcement as on 20 November 2025

Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales
LLY???s newest approvals and pipeline deals add fresh momentum to revenue growth as the company expands beyond its GLP-1 blockbusters.
Announcement as on 20 November 2025

Eli Lilly wants to be part of making a big dent in obesity and diabetes, says co's India head Winselow Tucker
Eli Lilly India chief Winselow Tucker said the company’s strategy of combining a strong product with ecosystem partnerships and patient education has helped drive early momentum for Mounjaro in India, where the dual-action diabetes and obesity drug has clo
Announcement as on 19 November 2025

Eli Lilly get nod from CDSCO for it Alzheimer’s drug Donanemab
Eli Lilly has secured marketing authorization from India's CDSCO for its Alzheimer's drug, donanemab. This new disease-modifying therapy targets amyloid plaques, offering a significant milestone in addressing the urgent needs of early-stage Alzheimer's pat
Announcement as on 18 November 2025

Announcements by Eli Lilly And Company first page | Next page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 1007.53
  • 12Day Average: 1046.45
  • 20Day Average: 1037.87
  • 50Day Average: 914
  • 100Day Average: 825.33
  • 150Day Average: 806.38
  • 200Day Average: 811.31

LLY Indicators & signals

Indicator MACD (12,26,9)

1022.48, 995.58, 44.18
Indicator MACD is in positive zone

Indicator ADX (14)

14.55, 20.83, 27.92
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Tue Dec 2025 982.22 979.18 to 1012.00 -1.54% 1.02 times
08 Mon Dec 2025 997.59 988.88 to 1014.20 -1.21% 1.22 times
05 Fri Dec 2025 1009.77 1004.00 to 1027.39 -0.47% 0.51 times
04 Thu Dec 2025 1014.49 1007.18 to 1032.63 -1.85% 1.54 times
03 Wed Dec 2025 1033.56 1022.32 to 1051.48 -1.13% 1.37 times
02 Tue Dec 2025 1045.37 1040.36 to 1068.18 -1.18% 0.67 times
01 Mon Dec 2025 1057.89 1055.00 to 1084.15 -1.63% 1.22 times
28 Fri Nov 2025 1075.47 1067.69 to 1099.05 -2.67% 1.09 times
26 Wed Nov 2025 1104.92 1098.10 to 1119.15 -0.42% 0.55 times
25 Tue Nov 2025 1109.59 1065.99 to 1111.11 4% 0.92 times
24 Mon Nov 2025 1066.88 1000.01 to 1075.72 0.68% 0.9 times
21 Fri Nov 2025 1059.70 1038.00 to 1066.65 1.57% 1.7 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared USA

 

Back to top